Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SNDA · against 404 other Healthcare companies of similar size
Ranked #37 of 405 · scores higher than 90% of peers
Bars: peers in each 10-point band of the growth score40 peers with a growth score of 90–100, including SNDA · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | SNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 408 reported | 49.4% | 6.2% | 91% | 33% | |
| Earnings per share growthHigher is better · 223 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 396 reported | 29.0% | 6.9% | 86% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 34 | 1.5B USD | 91 | 93 | |
| 34 | 3.1B USD | 91 | 46 | |
| 37 | 2.21T KRW (≈$1.6B) | 90 | 57 | |
| 37 | 2.29T KRW (≈$1.6B) | 90 | 88 | |
| 37 | 1.6B USD | 90 | 43 | |
| 37 | 2.1B USD | 90 | 61 | |
| 41 | 1.18T KRW (≈$847M) | 89 | 63 | |
| 41 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 41 | 6.8B CNY (≈$959M) | 89 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score